欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Ras-Raf-MAPK-ERK Pathway-Ras-RNK08954
RNK08954

Chemical Structure : RNK08954

CAS No.: 3032602-44-8

RNK08954 (RNK-08954, RNK 08954)

货号: PC-25973Not For Human Use, Lab Use Only.

RNK08954 is a potent, selective, non-covalent and orally bioavailable KRAS G12D inhibitor, binds primarily to the inactive KRAS G12D (GDP-bound) with SPR KD of 39.5 pM and to the active KRAS G12D (GTP-bound) form with KD of 12.2 nM.

规格 价格 库存 数量
50 mg Get quote
100 mg Get quote
250 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

RNK08954 is a potent, selective, non-covalent and orally bioavailable KRAS G12D inhibitor, binds primarily to the inactive KRAS G12D (GDP-bound) with SPR KD of 39.5 pM and to the active KRAS G12D (GTP-bound) form with KD of 12.2 nM.
RNK08954 shows overall higher binding affinity to KRAS WT, KRAS G12C and KRAS G12V proteins.
RNK08954 showsconcentration-dependent inhibition of p-ERK1/2 levels in human pancreatic adenocarcinoma cell line SW1990, performs better than MRTX1133, also demonstrates time- and concentration-dependent inhibition of p-AKT level.
RNK08954 exhibits potent inhibition with IC50 ranging from 2.6 nM to 49.5 nM in human tumor cells with KRAS G12D mutation and shows selectivity against cells with KRAS WT and other non-G12D KRAS mutations, with IC50 value of RNK08954 higher than 300 nM.
RNK08954 significantly inhibits cell viability in cells with KRAS G12D mutation with median IC50 of 10.8 nM in CTG assays in Ba/F3 cell lines.
RNK08954 induces cell cycle arrest in G0/G1 phase in a dose-dependent manner, and lead to cell death.
RNK08954 exhibits anti-tumor activity in KRAS G12D mutant CDX and PDX models, inducing 70% tumor regression in mice bearing GP2d xenograft administered 60 mg/kg (QD), 100% tumor regression at the 100 mg/kg twice a day (BID) in Panc 04.03 xenograft.

物理化学性质&存储条件

分子量 638.72
分子式 C36H36F2N6O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-(2-((1-((3-azabicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methoxy)-4-((1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-5-methoxypyrido[4,3-d]pyrimidin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-ol

参考文献

1. Xie L, et al. Cancer Discov. 2026 Jan 21. doi: 10.1158/2159-8290.CD-25-1346.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: